|
Volumn 7, Issue 6, 2011, Pages 312-
|
Rituximab for refractory SLE-patients reach lasting remission with short-term regimen
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
METHYLPREDNISOLONE;
PLACEBO;
PREDNISONE;
RITUXIMAB;
CLINICAL EFFECTIVENESS;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
FOLLOW UP;
HUMAN;
HUMORAL IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
NOTE;
PRIORITY JOURNAL;
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS;
RELAPSE;
REMISSION;
SHORT COURSE THERAPY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
|
EID: 79958099212
PISSN: 17594790
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2011.56 Document Type: Note |
Times cited : (5)
|
References (0)
|